“Currently, there's no treatment or vaccination on the market for human metapneumovirus, and there’s no combination vaccine,” said Vale-Freeburg, a Velocity sub-investigator. “So, its very ...

Vaccine Clinical trial Pneumonia Human metapneumovirus Winter viruses Older adults Severe symptoms Respiratory infections. ... noting the lack of existing vaccines for these viral infections.

Human metapneumovirus (HMPV), a respiratory virus affecting those with weakened immune systems, has sparked fresh concerns globally. With no vaccine available and immunity levels still uncertain ...

Human metapneumovirus, or hMPV, ... As yet, no licensed vaccine is available for the virus, but a series of candidates have entered early-stage clinical trials in the last two years.

MPV tends to hit hardest in young children, older adults and people with weakened immune systems. A virologist explains.

Despite being discovered in 2001, Human Metapneumovirus (HMPV) still lacks a vaccine, even after 24 years.

Reports of human metapneumovirus (HMPV), a common respiratory illness that causes flu- and cold-like symptoms, ... noting that there's no antiviral treatment and no vaccine to prevent HMPV, ...

In India, 7 cases of the Human metapneumovirus (hMPV) have been reported. This virus mainly affects young children, the elderly, and those with weak immune systems. In the meantime, following ...

HMPV in China: Amid the outbreak of human metapneumovirus (HMPV0 virus) in China, ... It spreads through respiratory droplets and currently has no vaccine.

The human metapneumovirus, also known as HMPV, is reportedly surging in China, raising questions about what the illness is and if it's a concern to those in the U.S.. Officials in India have also ...

China is facing a rise in respiratory infections, notably from rhinovirus and human metapneumovirus (HMPV), particularly in children under 14. Health experts warn against the indiscriminate use of ...